newcleo director holds options for 34,334 shares

The options are fully vested and expire on June 17, 2035.

Accepted by SEC EDGAR 09/21/2026 - 09:08 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

newcleo plc reports that director Anne-Francois de Bourdoncle de Saint Salvy held fully vested stock options covering 34,334 ordinary shares as of September 21, 2026. The options have an exercise price of 0.0228 per share and expire June 17, 2035.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider de Bourdoncle de Saint Salvy Anne-Francois

Role Director

Type	Security	Shares	Price	Value
Holding	Stock Options (Right to Buy) F1	--	--	--

Holdings: Stock Options (Right to Buy) — 34,334 contracts (Direct)

Footnotes (1)

1. F1. Represents fully vested stock options.

Key Figures

Underlying ordinary shares: 34,334 shares Exercise price: 0.0228 per share Expiration date: June 17, 2035

3 metrics

Underlying ordinary shares 34,334 shares Fully vested stock options held as of September 21, 2026

Exercise price 0.0228 per share Stock options

Expiration date June 17, 2035 Stock options

Key Terms

fully vested stock options, exercise price, Ordinary Shares

3 terms

fully vested stock options financial

"Represents fully vested stock options"

exercise price financial

"options with an exercise price of 0.0228"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Ordinary Shares financial

"underlying security for the stock options"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options does NWCL director Anne-Francois de Bourdoncle de Saint Salvy hold?

She held options covering 34,334 ordinary shares as of September 21, 2026. The options are fully vested, have an exercise price of 0.0228 per share, and expire June 17, 2035.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

de Bourdoncle de Saint Salvy Anne-Francois

(Last) (First) (Middle)

55 SOUTH AUDLEY STREET

(Street)

LONDON W1K2QH

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/21/2026

3. Issuer Name and Ticker or Trading Symbol
newcleo plc [ NWCL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(1)	06/17/2035	Ordinary Shares	34,334	$0.0228	D

Explanation of Responses:

1. Represents fully vested stock options.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kateryna Fedorova, attorney-in-fact for Anne-Francois de Bourdoncle de Saint Salvy	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)